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Neutralizing antibodies have been thought to be
required for protection against acutely cytopathic
viruses, such as the neurotropic vesicular stomatitis
virus (VSV). Utilizing mice that possess B cells but
lack antibodies, we show here that survival upon
subcutaneous (s.c.) VSV challenge was independent
of neutralizing antibody production or cell-mediated
adaptive immunity. However, B cells were absolutely
required to provide lymphotoxin (LT) a1b2, which
maintained a protective subcapsular sinus (SCS)
macrophage phenotype within virus draining lymph
nodes (LNs). Macrophages within the SCS of B cell-
deficient LNs, or of mice that lack LTa1b2 selectively
in B cells, displayed an aberrant phenotype, failed to
replicate VSV, and therefore did not produce type I
interferons, which were required to prevent fatal
VSV invasion of intranodal nerves. Thus, although B
cells are essential for survival during VSV infection,
their contribution involves the provision of innate
differentiation and maintenance signals to macro-
phages, rather than adaptive immune mechanisms.
INTRODUCTION
Adaptive immunity, especially neutralizing antibody production,
is thought to play a critical role in controlling cytopathic viral
infections in mammals (Hangartner et al., 2006). However,
external barrier breach by rapidly replicating viruses can place
a host at risk long before adaptive immune components can
be mobilized. Indeed, mice infected with VSV, an acutely cyto-
pathic neurotropic rhabdovirus, can suffer fatal neuroinvasion
despite high neutralizing antibody titers (Iannacone et al.,2010). This observation led us to revisit the contribution of
humoral immune responses to survival after VSV infection.
Intravenous (i.v.) infection of mice with VSV elicits neutralizing
T cell-independent IgM and T cell-dependent IgG responses that
become detectable by days 4 and 7 postinfection, respectively
(Bachmann et al., 1994, 1996; Charan and Zinkernagel, 1986;
Karrer et al., 1997; Thomsen et al., 1997). Because B cell-
deficient or CD4+ T cell-deficient mice die after i.v. VSV infection,
it had been thought that neutralizing T cell-dependent antibodies
were absolutely required for survival (Bru¨ndler et al., 1996). In
addition to adaptive immune mechanisms, the naive host
response to VSV infection is characterized by type I interferon
(IFN-I) production, which precedes high-affinity antibodies and
is also required for survival (Mu¨ller et al., 1994; Steinhoff et al.,
1995). IFN-I can contribute to humoral immunity by directly
enhancing B cell responses (Bach et al., 2007; Le Bon et al.,
2006; Swanson et al., 2010), and it also triggers cell-intrinsic anti-
viral resistance in somatic cells, including neurons (Detje et al.,
2009; Trottier et al., 2005).
Most studies exploring the role of antibodies during VSV infec-
tion have challenged mice via the i.v. route (Bachmann et al.,
1997; Bru¨ndler et al., 1996). However, VSV is usually transmitted
in the wild by bites of infected insects (Smith et al., 2009), so
subcutaneous (s.c.) infection arguably represents a more physi-
ological route. We have recently characterized the fate of VSV
and the resulting immune response after s.c. deposition of
a small VSV inoculum in the footpad of mice (Iannacone et al.,
2010; Junt et al., 2007). Intact virions are rapidly transported
from the injection site via lymphatics to the draining popliteal
lymph node (LN). LNs play a critical role in host defense by
providing a specialized environment to stage adaptive immune
responses and by acting as filter stations to prevent systemic
dissemination of lymph-borne pathogens (Junt et al., 2007; von
Andrian and Mempel, 2003). The cellular constituents of this
LN filter are CD169+ macrophages that line the principal lymph
conduits: the SCS and the medullary sinuses (Carrasco and
Batista, 2007; Junt et al., 2007; Phan et al., 2007). AlthoughImmunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc. 415
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B Cell-Dependent Innate Immunitymacrophages capture VSV in both the SCS and themedulla, viral
replication is anatomically restricted to CD169hi SCS macro-
phages, whereas CD169+/lo medullary macrophages are refrac-
tory to VSV infection (Iannacone et al., 2010). Their unique
permissiveness to productive VSV infection allows SCS macro-
phages to sense viral presence and rapidly commence IFN-I
production, which in turn protects intranodal nerves from VSV
replication and ultimately precludes viral ascension to the CNS
(Iannacone et al., 2010). Consequently, in macrophage-depleted
LNs, the intranodal nerves are vulnerable to VSV infection.
We have shown recently that the susceptibility to VSV neuro-
invasion upon LN macrophage depletion has a fatal outcome in
60% of infected mice, with both dying and surviving animals
producing similar neutralizing antibody titers (Iannacone et al.,
2010). Thus, humoral immunity was apparently not sufficient
for most individuals’ survival of s.c. VSV infection, although it re-
mained possible that antibodies afforded viral clearance in the
surviving 40% of mice. To clarify the role of B cells and anti-
bodies and to re-examine the requirements for protection
against VSV, we undertook the present study. By utilizing
animals that selectively lack antibodies but retain B cells, we
found that neither humoral nor cell-mediated adaptive immunity
were required for protection against VSV. However, B cells were
essential because they provided a critical source of LTa1b2
required for proper SCS macrophage differentiation. In the
absence of B cells, SCS macrophages lost their permissiveness
to VSV replication and failed to produce IFN-I, which enabled
lymph-borne VSV to access intranodal nerves as a conduit for
fatal CNS invasion.
RESULTS
Antibodies, but Not B Cells, Are Dispensable for
Protection against Subcutaneous VSV Infection
Previous studies have shown that B cell-deficient mice are highly
susceptible to acutely cytopathic viruses, including VSV (Bach-
mann et al., 1995; Bru¨ndler et al., 1996; Gobet et al., 1988; Hang-
artner et al., 2006). Although this finding was interpreted as
evidence that antibodies are absolutely required, it must be
considered that B cell-deficient mice not only lack antibodies
but also display abnormal lymphoid architecture (Kitamura
et al., 1991). Therefore, we sought to re-evaluate the relative
contribution of antibody-dependent and -independent functions
of B cells to protective immunity against VSV. We took advan-
tage of a recently generated mouse strain, DHLMP2A, in which
the JH segment of the IgH locus was replaced by the Epstein-
Barr virus-derived LMP2A protein (Casola et al., 2004). Because
LMP2A provides tonic survival signals, B cells develop without
a B cell receptor; therefore, DHLMP2A mice retain B cells and
normal lymphoid tissue architecture, yet are devoid of surface-
expressed and secreted antibodies.
Consistent with previous studies (Bru¨ndler et al., 1996), B cell-
deficient (mMT)mice diedwithin 10 days of i.v. infection, whereas
WTmice survived the viral challenge (Figure 1A). DHLMP2Amice
were also susceptible to death after i.v. VSV infection, with a clin-
ical course and mortality rate that were indistinguishable from
those of mMT mice (Figure 1A). However, when mice were
challenged s.c. (the natural transmission route for arboviruses,
such as VSV [Mead et al., 1999]), 60% of mMT mice died after416 Immunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc.developing ascending paralysis. In contrast, DHLMP2Amice, like
WTmice, were protected (Figure 1B), even though (as expected)
they were incapable of mounting a neutralizing antibody
response to VSV (Figure 1C). Susceptibility to death in mMT
mice after s.c. infection was a consequence of neuroinvasion
by VSV, as indicated by the fact that virus became detectable
in the CNS in symptomatic mMT mice. By contrast, VSV was
never detectable in the systemic circulation (Figure S1 available
online), indicating that the site of VSV entry to the CNS was the
peripheral nervous system in the infected hindleg. Indeed,
previous studies on the route of viral neuroinvasion after footpad
infection have shown that VSV invades peripheral nerve fibers
in the draining popliteal LN to gain access into the CNS (Ianna-
cone et al., 2010).
Although our results after i.v. viral challenge support an anti-
body requirement for survival of acutely cytopathic viral infection
(Bachmann et al., 1997; Bru¨ndler et al., 1996), our findings in the
s.c. infectionmodel are not compatible with this antibody-centric
paradigm. Rather, our findings in DHLMP2A mice imply that
B cells may have an additional innate role in antiviral immunity
that must be antibody independent.
B Cells Are Required for SCS Macrophage-Dependent
IFN-I Production upon VSV Infection
With the footpad VSV infectionmodel, we have previously shown
that IFN-I production by macrophages in the draining popliteal
LN is essential for survival of the viral challenge (Iannacone
et al., 2010). Therefore, we examined the production of IFN-I
family members in virus-draining LNs of mMT and DHLMP2A
mice. When compared to WT animals, IFN-I production in
VSV-draining LNs was reduced in mMT mice, but not in
DHLMP2A mice, indicating that B cells, and not antibodies, are
required for optimal IFN-I production upon VSV infection (Figures
1D and 1E). In VSV-challenged WT animals, IFN-I is largely
produced by infected SCS macrophages and exerts its protec-
tive function by acting on intranodal nerves to prevent viral
neuroinvasion (Iannacone et al., 2010). Indeed, LN macrophage
depletion in WT mice results in a clinical course, mortality rate,
and suppressed IFN-I response after s.c. VSV infection (Ianna-
cone et al., 2010) that are reminiscent of those in mMT animals.
Thus, we reasoned that the difference in viral susceptibility
between mMT mice and DHLMP2A animals might reflect a diver-
gence in LN macrophage composition and/or function.
As lymph drains from peripheral tissues and enters LN
sinuses, it flows past two discrete macrophage populations: first
the CD169hi subset in the SCS and, subsequently, CD169+/lo
macrophages in the medulla. In WT mice, these two macro-
phage subsets can be distinguished not only by virtue of their
anatomical location and differential expression of CD169, but
also by several other surface markers. One such marker is the
C-type lectin SIGN-R1, which in WT mice is highly expressed
by medullary but not SCS macrophages (Figures 2A and 2B;
Kang et al., 2004). By contrast, mMT mice not only expressed
CD169 more uniformly, but also SIGN-R1 was expressed homo-
geneously by macrophages within both the SCS and medulla
(Figures 2A and 2B). Lymphatic endothelial cells in the medullary
sinuses express high levels of Lyve-1, so staining for Lyve-1 is
useful to localize medullary and SCS macrophages in LN
sections, especially in mMT mice where the absence of B cell
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Figure 1. Antibodies, but Not B Cells, Are
Dispensable for Protection against Subcu-
taneous VSV Infection
(A) Kaplan-Meier survival curves of C57BL/6
(n = 9), BALB/c (n = 10), mMT (C57BL/6 back-
ground; n = 5), and DHLMP2A (BALB/c back-
ground; n = 6) mice infected with 106 pfu of
VSV-IND i.v. DHLMP2A versus mMT: p = 0.51,
Log-rank (Mantel-Cox) test.
(B) Kaplan-Meier survival curves of C57BL/6
(n = 93), BALB/c (n = 30), mMT (n = 50), and
DHLMP2A (n = 36) mice infected with 10
4 pfu of
VSV-IND i.fp. DHLMP2A versus mMT: p < 0.0001,
Log-rank (Mantel-Cox) test.
(C) VSV neutralizing antibody titers in the sera of
the mice described in (B), 15 days after infection.
Graph is representative of two experiments (n = 4
per experiment); ND = not detected.
(D and E) Ifnb1 (D) and Ifna2 (E) mRNA levels in
total RNA isolated from LNs of the animals
described in (B) and sacrificed 8 hr p.i. Analysis
was performed by quantitative RT-PCR and
results are expressed as relative units (RU) after
normalization to the mRNA content of the house-
keeping gene GAPDH. Graphs are representative
of two experiments (n = 3 per experiment). **p <
0.001, *p < 0.05.
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B Cell-Dependent Innate Immunityfollicles and homogeneous SIGN-R1 expression make distinc-
tion of SCS and medullary regions less apparent (Figure S2).
Aberrant expression of SIGN-R1 was seen in mMT mice, but
not in DHLMP2A mice, whose LNs contained somewhat fewer
macrophages than strain-matchedWT LNs (not shown), but their
SCS macrophage population was phenotypically indistinguish-
able from both C57BL/6 and BALB/c WT controls (Figures 2A
and 2B). Consequently, in single-cell suspensions of LNs from
the latter three strains, only 40% of macrophages displayed
a medullary phenotype, whereas 90% of macrophages were
SIGN-R1+ in mMT LNs (Figure 2C). These findings are consistent
with recent work indicating that B cell-deficient mice have
a reduced number of LN macrophages and show aberrant
expression of F4/80 (another surfacemarker restricted tomedul-
lary macrophages in WT mice) on SCS macrophages (Phan
et al., 2009).
Previous work has shown that both SCS and medullary
macrophages rapidly capture virions that access LNs via afferent
lymphatics (Junt et al., 2007). Other studies employing footpadImmunity 36, 415–42infection with eGFP transgenic VSV
(VSV-eGFP), which reports viral protein
expression in infected cells (Chandran
et al., 2005), demonstrated that medullary
macrophages captured but did not
replicate VSV (Iannacone et al., 2010).
By contrast, SCS macrophages uniquely
expressed GFP, indicating that they
became preferentially infected (Hickman
et al., 2008; Iannacone et al., 2010).
When whole mounts of popliteal LNs
were examined by confocal or multi-
photon microscopy 8 hr after footpadinfection with VSV-eGFP, GFP was not uniformly distributed
but appeared most prominent above cortical bulges indicative
of underlying B follicles (Movie S1). Indeed, experiments in LNs
that had been populated by adoptively transferred differentially
labeled T and B cells revealed that the majority of VSV-eGFP+
macrophages were in direct physical contact with follicular B
cells, whereas GFP expression was absent in the medulla and
sparse among SCS macrophages in the interfollicular T cell
area (Movies S2 and S3).
The apparent correlation between B cell-macrophage interac-
tions and VSV replication capacity led us to test whether anti-
bodies or B cell deficiency altered viral capture or infectivity of
LN macrophages after s.c. VSV challenge. Thirty minutes after
footpad injection, both mMT and DHLMP2A LNs efficiently
captured and retained lymph-borne VSV at levels similar to WT
controls (Figures 3A and 3B). Thus, the defect in macrophage
number and surface phenotype in mMTmice did not compromise
LN filter function. However, mMT LNmacrophages failed to repli-
cate VSV-eGFP, whereas WT and DHLMP2A mice showed6, March 23, 2012 ª2012 Elsevier Inc. 417
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Figure 2. Surface Phenotype of SCS Macrophages in WT, mMT, and
DHLMP2A Mice
(A) Representative confocal micrographs of frozen popliteal LN sections
stained with MAbs against SIGN-R1 (red), and CD169 (green). Scale bars
represent 100 mm.
(B) FACS histograms of SIGN-R1 expression on CD11b+CD169+ LN cells of
the indicated mouse strains. Histograms are representative of three experi-
ments (n = 3–4 mice/experiment).
(C) Percentage of SIGN-R1+ cells within the CD11b+CD169+ compartment in
LNs of the indicated mouse strains. ***p < 0.001.
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418 Immunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc.robust VSV-eGFP replication that was restricted to SCS macro-
phages (Figure 3C). Accordingly, 8 hr after VSV challenge, mMT
LNs contained nearly undetectable levels of replicating VSV,
whereas substantial viral titers were apparent in WT and
DHLMP2A LNs (Figure 3D). SCS macrophages are thought to
produce IFN-I only when they are actively infected (Iannacone
et al., 2010), so the failure of mMTmacrophages to replicate virus
in the SCS was probably the cause of their impaired IFN-I
production (Figures 1D and 1E). Together these data imply that
follicular B cells in LNs instruct a macrophage phenotype that
is conducive to VSV replication, which appears necessary for
subsequent local IFN-I production and ultimately the prevention
of fatal CNS neuroinvasion after s.c. VSV infection.
Consistent with this interpretation, depletion of LN macro-
phages by footpad CLL injection did not further decrease IFN-I
production in mMT LNs (Figures 4A and 4B), nor did it enhance
susceptibility to viral neuroinvasion (Figure 4C). However, when
CLL was used to deplete LN macrophages from DHLMP2A or
WT mice prior to infection, LN IFN-I production was greatly
diminished (Figures 4A and 4B). Moreover, CLL-treated animals
became susceptible to death after s.c. VSV infection with clinical
course and mortality rate that were identical to those of mMT
mice (Figure 4C). Thus, the antibody-independent survival of
DHLMP2A animals is dependent upon the presence of functional
SCS macrophages.
B Cell-Derived LTa1b2 Maintains the Protective
Antiviral Phenotype of SCS Macrophages
B cell contributions to the development of secondary lymphoid
organs (Mebius, 2003) and the homeostasis of their stromal
architecture and function (Schneider et al., 2008) are well known.
A key homeostatic signal provided by B cells is LTa1b2, a TNF
family member. B cell-expressed LTa1b2 controls splenic
macrophage phenotype (Tumanov et al., 2002; Yu et al., 2002)
and maintains the number and phenotype of SCS macrophages
in LNs (Phan et al., 2009), but the role of this pathway in antiviral
immunity is less understood. To explore this question, we treated
WT mice for 2–3 weeks with LTbR-Ig, a decoy receptor that
blocks lymphotoxin signaling (Fava et al., 2003). SCS macro-
phages in LTbR-Ig-treated LNs acquired SIGN-R1 (Figures 5A–
5D) and lost expression of ligands for the cysteine-rich domain
of the mannose receptor (CR-Fc), which are normally abundant
on SCS macrophages but absent from the medulla (Figure S3).
SIGN-R1 and CD169 expression by medullary macrophages
was grossly unaffected by LTbR-Ig (Figures 5E and 5F). Thus,
lymphotoxin blockade induced phenotypic changes in WT SCS
macrophages that were strikingly similar to those in mMT LNs
(Figures 2 and S3). Moreover, similar to B cell-deficient mice
(Figure 3), the initial capture of lymph-borne VSV by LN macro-
phages was not affected by LTbR-Ig treatment (Figure 5G), but
the capacity of treated LN macrophages to replicate VSV-
eGFP (Figures 6A–6E) and to secrete IFN-I (Figures 6F and 6G)
was compromised. We conclude that lymphotoxin signaling is
dispensable for the lymph-filtering function of LN macrophages,
but required to establish VSV replication competence and IFN-I
production by SCS macrophages.
We have previously shown that SCS macrophage-derived
IFN-I prevents VSV infection of peripheral nerves within draining
LNs and ultimately protects against fatal neuroinvasion
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Figure 3. B Cells Are Required for VSV
Replication in LN Macrophages
(A) Representative confocal micrographs of
popliteal LN sections 30min after footpad infection
with Alexa Fluor 488-labeled VSV (VSV488, green).
Sections were stained with MAbs against CD169
(red) and B220 (blue). Scale bars represent
100 mm.
(B) Viral titers in popliteal LNs of mice infected
30 min earlier with VSV-IND into the footpad.
Results are representative of two experiments (n =
4 per experiment).
(C) Representative confocal micrographs of
popliteal LN sections 8 hr after footpad infection
with VSV-eGFP (green). Sections were stained as
in (A). Scale bars represent 150 mm.
(D) Viral titers in popliteal LNs 8 hr after footpad
infection with VSV-IND. Results are representative
of three experiments (n = 3–4 mice/experiment).
Immunity
B Cell-Dependent Innate Immunity(Iannacone et al., 2010). Consistent with these data, and similar
to our findings in mMT animals, the majority of LTbR-Ig-treated
WT mice died within 10 days of s.c. VSV infection (Figure 7A).
LTa1b2 expression is not restricted to B cells but is found on
other cell types (Junt et al., 2006), particularly activated CD4+
T cells (Millet and Ruddle, 1994), and inflammatory signals can
upregulate LTa1b2 on other LN cells (Agyekum et al., 2003).
However, because of the spatial proximity between B cells and
SCS macrophages within normal LNs, B cells seemed the
most likely source of relevant LTa1b2 in this system. To formally
test this prediction, we used B Ltb/ mice that lacked LTa1b2
selectively in B cells (Tumanov et al., 2002). To avoid potential
effects of compromised lymphoid organogenesis and disturbed
lymphoid architecture in these animals, B Ltb/ or WT bone
marrow was used to reconstitute irradiated WT recipients.
Bone marrow chimeric mice that lacked LTa1b2 specifically in
T cells (T Ltb/) served as additional controls. Similar to obser-
vations in LTbR-Ig-treated animals, B Ltb/ chimeric animals
failed to replicate VSV within SCS macrophages after s.c.
infection (Figures S4A and S4B), and 60% of them died with
signs of ascending paralysis, characteristic of peripheral VSV
neuroinvasion (Figure 7A). By contrast, T Ltb/ mice were pro-
tected against s.c. VSV challenge, confirming that B cells are
the critical source of LTa1b2 that maintains protective SCS
macrophages within peripheral LNs.
Adaptive Immunity Is Dispensable during Primary
SubcutaneousVSV Infection
Most macrophage-depleted WTmice died when challenged s.c.
with VSV even though they possessed neutralizing antibodyImmunity 36, 415–42titers that were much higher than in
macrophage-sufficient animals (Ianna-
cone et al., 2010). In fact, antibody titers
were indistinguishable between macro-
phage-depleted WT mice that suc-
cumbed to VSV infection and those that
remained asymptomatic (Figure S4C).
Although the mechanism by which CLL-
induced macrophage depletion leads toincreased antibody titers in this model remains to be determined,
these data, together with our findings in DHLMP2A mice, firmly
establish that antibodies are neither required nor sufficient for
survival of a primary s.c. infection with VSV.
This observation raised the question whether adaptive immu-
nity mediated by other lymphocytes is required for protection
against peripheral VSV infection. Indeed, both T cells (Ku¨ndig
et al., 1996; Zinkernagel et al., 1978) and a subset of Thy1+
natural killer cells (Paust et al., 2010) can mount virus-specific
effector and memory responses against VSV. To address this
question, DHLMP2A mice were depleted of these adaptive
lymphocytes by administration of Thy1 antibodies, which re-
sulted in greater than 95% loss of circulating T cells (Figures
S4D and S4E). Remarkably, despite the complete lack of both
humoral and cellular adaptive immunity, all anti-Thy1-treated
DHLMP2Amice survived VSV infection (Figure 7B). This indicates
that the innate immune system, particularly the presence of fully
differentiated SCS macrophages, provides sufficient protection
to clear this acutely cytopathic viral infection without the need
for adaptive immunity.
DISCUSSION
The results presented here contradict the current view that B
cell-derived neutralizing antibodies are absolutely required to
survive a primary cytopathic viral infection, such as that caused
by VSV. This paradigm arose originally from experiments in B
cell-deficient mice (Bachmann et al., 1994, 1997; Bru¨ndler
et al., 1996; Gobet et al., 1988), which lack antibodies, but also
have abnormal lymphoid tissue architecture and altered6, March 23, 2012 ª2012 Elsevier Inc. 419
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Figure 4. LN Macrophage Depletion Renders Antibody-Deficient Mice Susceptible to Fatal VSV Neuroinvasion
(A) Ifnb1 (left), Ifna2 (middle), and Ifna4 (right) mRNA levels in total RNA isolated from LNs of the indicated mouse strains, with or without clodronate liposomes
(CLL) treatment, 8 hr after footpad infection with VSV-IND. Analysis was performed as indicated in Figures 1D and 1E. Graphs are representative of two
experiments (n = 3–4 per experiment). ***p < 0.001, *p < 0.05.
(B) The same set of data as in (A) are expressed as: (mRNA levels in CLL-treated LNs)/(mRNA levels in control LN) 3 100.
(C) Kaplan-Meier survival curves of C57BL/6 (n = 93), BALB/c (n = 30), and DHLMP2A with (n = 12) or without (n = 36) CLL treatment, and mMT with (n = 15) or
without (n = 50) CLL treatment prior to footpad infection with VSV-IND. DHLMP2A versus DHLMP2A + CLL: p < 0.0001; mMT versus mMT + CLL: not significant;
mMT versus DHLMP2A + CLL: not significant; Log-rank (Mantel-Cox) test.
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B Cell-Dependent Innate Immunitymacrophage phenotype. Our experiments in mice that lack anti-
bodies but possess B cells and normal lymphoid tissues confirm
that both B cells and antibodies are critical to survive a systemic
infection after i.v. bolus administration of VSV. However, only B
cells are essential when VSV is encountered via the more
‘‘natural’’ s.c. route, whereas antibodies are neither needed nor
sufficient for protection. Our data collectively indicate that immu-420 Immunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc.nity to s.c. VSV infection relies on B cell-derived LTa1b2,
rendering SCS macrophages capable of replicating VSV and
producing neuroprotective IFN-I.
Although VSV infections are typically self-limiting in mammals,
rabies virus, a close relative, is responsible for >55,000 human
deaths every year. Neutralizing antibodies are also believed to
be required to survive rabies infections, as shown by the fact
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Figure 5. LT Signaling Is Required for SCS Macrophage Differentia-
tion but Is Dispensable for LN Viral Capturing
(A–F) Representative confocal micrographs of LN sections from control
(A, C, E) and LTbR-Ig-treated (B, D, F) C57BL/6 mice, stained with MAbs
against CD169 (green) and SIGN-R1 (red). Panels (C) and (D) are high-
magnification images of SCS regions, and (E) and (F) are high-magnification
images of medullary regions. Scale bars represent 100 mm (A, B) and
20 mm (C–F).
(G) Viral titers in popliteal LNs of C57BL/6, mMT, and LTbR-Ig-treated C57BL/6
mice, 30 min after footpad VSV infection. Results are representative of two
experiments (n = 3–4 per experiment). Differences among means are not
statistically significant.
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humoral immunity are standard of care. Although neutralizing
antibodies are undoubtedly effective prophylaxis against rhab-
doviruses, our findings indicate that antibody therapy may be
insufficient to treat existing rhabdoviral infections in nonimmune
subjects, at least in the case of VSV. It is unclear whether this
caveat applies also to rabies virus infection, but failures of both
passive and active vaccination after exposure to rabies are
known to occur (Anonymous, 1988). Thus, it will be important
to further dissect the role of antibodies and interferon in this
disease. In addition, recent years have seen the emergence
and/or spread of other arthropod-borne neurotropic viral infec-
tions, such as West Nile virus, Japanese encephalitis virus,
and Eastern and Western equine encephalitis virus, to name
a few (Weaver and Barrett, 2004). It remains to be determined
whether the cellular and molecular immunological events that
occur upon inoculation of these pathogens in the skin are similar
to the ones identified here.
Most viral pathogens, including rabies and VSV, must breach
the body’s external barriers to cause disease. Viruses deposited
in the interstitial space of peripheral tissues are readily drained
via lymph vessels to downstream LNs. Once a lymph-borne virus
enters the intranodal lymph conduits, it runs a gauntlet across
two phenotypically and functionally distinct LN macrophage
populations within the lymphatic space. Initial encounter is with
SCS macrophages, which populate the superficial cortex above
B cell follicles, often with macrophages penetrating across the
sinus floor such that they contact both follicular B cells and
afferent lymph (Junt et al., 2007). Subsequently, lymph-borne
viruses are exposed to macrophages within medullary sinuses
where lymph is collected to be discharged into efferent
lymphatics. Together, SCS and medullary macrophages filter
the lymph and capture particulate matter, including viruses
(Junt et al., 2007). The recognition mechanism(s) mediating this
‘‘flypaper’’ activity is not fully understood, but this process is
extremely effective, as shown by the fact that >99% of infectious
virions are retained in LNs, preventing systemic dissemination
(Junt et al., 2007).
Once a lymph-borne virus has been captured by LN macro-
phages, at least three distinct fates await the surface-bound
virion: (1) phagocytosis and destruction in lysosomal compart-
ments, (2) presentation and handover to follicular B cells for
the induction of humoral responses, or (3) productive infection
of the capturing cells (Iannacone et al., 2010; Junt et al., 2007).
Paradoxically, our findings indicate that the latter event is indis-
pensable for host resistance to VSV; infected mice survived
efficiently when SCS macrophages supported VSV replication.
Although both SCS and medullary macrophages captured
VSV, only SCS macrophages support VSV replication, which is
required for IFN-I production (Iannacone et al., 2010). In settings
where SCS macrophage differentiation was compromised, as in
mMT mice, the cells failed to replicate VSV or to produce IFN-I,
which is required to protect intranodal nerves from serving as
viral conduits to the CNS.
Several phenotypic and functional features of SCS andmedul-
lary macrophages could regulate their difference in VSV replica-
tion capacity. For example, medullary macrophages are more
phagocytic and express higher levels of endosomal degradative
enzymes than their SCS counterparts (Delemarre et al., 1990b;Immunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc. 421
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Figure 6. LT Signaling Is Required for LN VSV Replication and IFN-I Production
(A–D) Representative confocal micrographs of LN sections from control (A, C) and LTbR-Ig-treated (B, D) C57BL/6 mice at 8 hr after footpad infection with VSV-
eGFP (green). Sections were stained with MAbs against CD169 (red) and B220 (blue). Scale bars represent 150 mm (A, B) and 100 mm (C, D).
(E) Viral titers in popliteal LNs of C57BL/6, mMT, and LTbR-Ig-treated C57BL/6 mice, 8 hr after footpad VSV infection. Results are representative of three
experiments (n = 4 per experiment). ***p < 0.001.
(F and G) Ifnb1 (F) and Ifna2 (G) mRNA levels in total RNA isolated from LNs of mMT and C57BL/6mice that were treated with CLL or with LTbR-Ig for 1 or 2 weeks
prior to infection with VSV-IND. Mice were sacrificed 8 hr p.i. Analysis was performed as indicated in Figures 1D and 1E. Graphs are representative of two
experiments (n = 3–4 per experiment). ***p < 0.001; **p < 0.01; *p < 0.05.
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B Cell-Dependent Innate ImmunityFossum, 1980; Phan et al., 2009; Sainte-Marie and Peng, 1985;
Szakal et al., 1983). The two subsets differ also in their expres-
sion of antiviral sensing receptors. Compared to SCS macro-
phages, published microarray data (Phan et al., 2009) suggest
that the medullary subset expresses higher mRNA levels for
several TLRs, including TLR4 and TLR13, which both recognize
VSV (Georgel et al., 2007; Shi et al., 2011). By contrast, SCS
macrophages express more RIG-I, which enables intracellular422 Immunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc.VSV recognition (Gerlier and Lyles, 2011; Kato et al., 2006).
Thus, medullary macrophages are well equipped to detect and
destroy extracellular virus whereas SCS macrophages appear
to be relatively inefficient at eliminating surface-bound virions,
which may facilitate productive VSV infection. However, SCS
macrophages may be preferentially responsive to viral patterns
in their cytoplasm, inducing IFN-I production. Similar to differ-
ences between SCS andmedullary macrophages inWT animals,
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Figure 7. B Cell-Derived LTa1b2 Is Required for
Survival upon Subcutaneous VSV Infection,
although Adaptive Immunity Is Dispensable
(A) Kaplan-Meier survival curves of footpad VSV-
infected C57BL/6 (treated or not with LTbR-Ig), mMT, or
irradiated C57BL/6 mice that were reconstituted with
Lta/, B Ltb/, or T Ltb/ bonemarrow (BM). C57BL/
6 versus B Ltb/BM/C57BL/6, p < 0.0001; C57BL/6
versus T Ltb/ BM / C57BL/6, not significant; B
Ltb/ BM/ C57BL/6 versus C57BL/6 + LTbR-Ig, not
significant; B Ltb/ BM/ C57BL/6 versus mMT, not
significant; B Ltb/ BM / C57BL/6 versus Lta/
BM/ C57BL/6, not significant; Log-rank (Mantel-Cox)
test.
(B) Kaplan-Meier survival curves of C57BL/6, (n = 10)
BALB/c, (n = 10), and mMT (n = 13) DHLMP2A mice
that were untreated (n = 11) or treated with CLL alone
(n = 11), or Thy1 antibody alone (n = 15) or with CLL
and Thy1 antibody (n = 15) prior to footpad VSV
infection. BALB/c versus DHLMP2A + a-Thy1, not
significant; BALB/c versus DHLMP2A + a-Thy1 + CLL,
p < 0.0001; DHLMP2A + a-Thy1 + CLL versus mMT, not
significant; DHLMP2A + a-Thy1 + CLL versus
DHLMP2A + CLL, not significant; Log-rank (Mantel-Cox)
test.
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B Cell-Dependent Innate Immunityour data would predict that SCS macrophages from DHLMP2A
and mMT mice are similarly divergent in their viral sensing and
phagocytic capacity.
LTbR is expressed on both LN macrophage subsets, but SCS
macrophage maintenance and function appear to be more
sensitive to LTbR signaling (Phan et al., 2009). Moreover, SCS
but presumably not medullary macrophages are in intimate
contact with LTa1b2-expressing follicular B cells. Consequently,
in vivo LTa1b2 inhibition minimally affects the medullary
compartment, but alters the phenotype of SCS macrophages
and compromises their ability to capture lymph-borne immune
complexes (Phan et al., 2009). The present findings indicate
that LTa1b2 also regulates SCS macrophage susceptibility to
VSV and the ensuing IFN-I response. In the absence of B cell-
expressed LTa1b2, SCS macrophages assume a phenotype
resembling medullary macrophages and no longer support
VSV replication. One possible explanation for this observation
is that tonic exposure to LTa1b2 on follicular B cells attenuates
macrophage responsiveness to autocrine IFN-I. Without LTbR
signaling, as is physiologically the case in the medulla or may
be experimentally achieved in the SCS by deletion of B cells or
treatment with LTbR-Ig, macrophages may gain IFN-I respon-
siveness and VSV resistance.
It remains to be determined whether there are additional
mechanisms by which B cell-derived LTa1b2 renders SCS
macrophages physiologically susceptible to VSV infection.
Nonetheless, the net effect is that LTa1b2 transforms SCS
macrophages into unique sentinels that execute a rapid antiviral
cytokine response. It seems counterintuitive that this defenseImmunity 36, 41mechanism should depend upon the amplifi-
cation of a potentially lethal virus, but beyond
jump-starting the IFN-I response, increased
viral antigen availability may facilitate adaptive
memory in LNs (Hickman et al., 2008). Thus,SCS macrophage infection appears to be a ‘‘necessary evil’’ to
ensure short-term survival and to promote long-term immunity
of the host.
Defects in LTa1b2 signaling have been implicated previously
in impaired antiviral immune responses (Berger et al., 1999;
Spahn et al., 2005). Efficient IFN-I production upon cytomegalo-
virus infection requires lymphotoxin signaling in splenic stromal
cells (Benedict et al., 2001; Schneider et al., 2008), and Ltb/
mice are vulnerable to death after i.v. VSV infection resulting
from defective viral capture by splenic marginal zone macro-
phages (Junt et al., 2006). However, these earlier studies per-
formed by systemic viral challenge were focused on the role of
LTa1b2 in antiviral responses mediated by adaptive immune
cells. Our findings highlight a previously underappreciated role
for lymphotoxin in innate antiviral immunity in LNs draining a local
infection site.
While LTa1b2 confers antiviral resistance to blood-borne or
lymph-borne VSV in the spleen or peripheral LNs, respectively,
our observations reveal the critical role that the route of infection
plays in determining the molecular and cellular requirements for
immune protection. Both i.v. and s.c. VSV infections elicit robust
IFN-I and neutralizing antibody production, and both infection
routes rely on macrophages for survival (Ciavarra et al., 2005;
Iannacone et al., 2010). Consistent with earlier findings (Thom-
sen et al., 1997), our experiments confirm that antibodies are
critical to survive i.v. VSV infection; however, a humoral response
is neither required nor sufficient to prevent fatal neuroinvasion
when VSV is given subcutaneously. In the s.c. setting, VSV gains
access to the CNS via peripheral nerves in draining LNs5–426, March 23, 2012 ª2012 Elsevier Inc. 423
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B Cell-Dependent Innate Immunity(Iannacone et al., 2010). It is unclear how VSV accesses the CNS
from the blood; however, it appears to do so rapidly, at least
when given at a lethal dose, because subsequent treatment
with neutralizing antibodies is protective only within 3 hr of i.v.
infection (Steinhoff et al., 1995).
VSV infection of SCS macrophages, although required for
production of neuroprotective IFN-I, results in death of the
host cells within 12–18 hr. Through this act of self-sacrifice,
SCS macrophages establish a local antiviral state that pre-
vents further viral replication. However, once depleted, SCS
and medullary macrophages are slow to return. When CLL is
used to eliminate essentially all LN macrophages, LNs require
as long as 6 months to re-establish normal cell numbers (Dele-
marre et al., 1990a). This lag time is markedly shorter after VSV
infection, where SCS macrophages return to preinfection
numbers within 1 month (data not shown). Nevertheless, the
void of SCS macrophages for several weeks after VSV infection
probably renders LNs transiently hypervulnerable to reinfection.
In these cases the induction of protective memory responses by
adaptive immune cells may be critical for preventing early
reinfection.
In contrast to the likely benefit of adaptive immunity during
reinfection, our results demonstrate that during a primary s.c.
infection, recognition of viral epitopes by either antibody or
TCR is neither necessary nor sufficient to prevent fatal VSV neu-
roinvasion. This observation runs counter to the commonly held
view that during viral infections, innate immunity must orches-
trate the induction of antiviral adaptive responses to achieve
sterilizing immunity. Given the rapid replication of some viruses,
a proliferating pathogen may overwhelm its host before adaptive
immune countermeasures can be mobilized. Innate defenses
like complement, type I interferon, and others are believed to
provide stopgap measures, lowering pathogen burden and
buying time for adaptive immune responses to develop.
Although this concept may apply to other viral infections, our
findings with VSV turn this view upside down, indicating that
during a primary infection with this cytopathic virus, innate
immunity can be sterilizing without adaptive immune contribu-
tions. Thus, the essential contribution to VSV immunity by adap-
tive immune cells appears to be 2-fold. (1) During primary
infection, B cells are critical enablers of innate immune
responses by inducing and maintaining SCS macrophage
phenotype through LTa1b2 presentation. (2) During secondary
infection in the presence of established immunological memory,
antiviral antibodies neutralize infectious virions before host cells
can be infected.
In summary, we demonstrate that naivemice can survive a s.c.
VSV challenge without requiring antigen-specific adaptive
immunity. Efficient protection against VSV is provided by SCS
macrophages in the draining LNs that rely on contact with follic-
ular B cells expressing LTa1b2 on their surface. The constant
exposure to LTa1b2 induces and maintains the protective SCS
macrophage phenotype. Consequently, SCS macrophages in
B cell-deficient mice or in mice that lack B cell-expressed
LTa1b2 display an altered phenotype that resembles that of
medullary macrophages, which are not protective in VSV infec-
tion. Like medullary macrophages, SCS macrophages that are
deprived of LTa1b2 capture lymph-borne VSV but fail to replicate
it. Without replication, SCS macrophages do not produce IFN-I424 Immunity 36, 415–426, March 23, 2012 ª2012 Elsevier Inc.that is required to prevent VSV invasion of intranodal nerves.
These findings establish a critical innate function for B cells in
antiviral immunity. This setting requires B cells not as a source
of antibodies, but as providers of an anatomically restricted
maintenance signal and as the day-to-day custodians of macro-
phage differentiation.
EXPERIMENTAL PROCEDURES
Full details of experimental procedures can be found online with Supplemental
Information.
Mice
C57BL/6 and BALB/c mice, 6–8 weeks old, were purchased from Charles
River or The Jackson Laboratory. DHLMP2A mice were provided by K. Rajew-
sky (Harvard Medical School). Lta-deficient and mMT mice were purchased
from The Jackson Laboratory. Radiation bone marrow chimeras were gener-
ated by transfer of C57BL/6, B Ltb/, T Ltb/, or Lta/ bone marrow into
C57BL/6 mice. Mice were housed under specific-pathogen-free conditions
in accordance with National Institutes of Health guidelines. All experimental
animal procedures were approved by the Institutional Animal Committees of
Harvard Medical School and IDI.
Viruses and Viral Plaque and Neutralization Assays
VSV serotype Indiana and VSV-eGFP (Chandran et al., 2005) were propagated
and purified as described (Iannacone et al., 2010; Junt et al., 2007). Some
batches were fluorescently labeled as described (Junt et al., 2007). Infectivity
of VSV preparations and VSV titers from organs of infected mice were quanti-
fied by plaque assay as described (Iannacone et al., 2010; Junt et al., 2007).
VSV neutralization assay was performed as described (Iannacone et al.,
2010; Junt et al., 2007). Mice were infected with 104 plaque-forming units
(pfu) of VSV Indiana into the right hind footpad (i.fp.), 106 pfu of VSV-eGFP
i.fp., 107 pfu of VSV488, or 106 pfu of VSV Indiana intravenously (i.v.). All infec-
tiouswork was performed in designated BL2+workspaces, in accordancewith
institutional guidelines, and approved by the Harvard Committee on Microbi-
ological Safety.
Tissue Digestion and Flow Cytometry
Single-cell suspensions of LNs for flow cytometry were generated as
described (Iannacone et al., 2010). All flow cytometric analyses were per-
formed and analyzed as described (Iannacone et al., 2010).
Confocal Microscopy
Popliteal LNs were harvested, processed, sectioned, stained, and analyzed as
described (Iannacone et al., 2010; Junt et al., 2007). Whole-mount immunoflu-
orescence analysis was performed as described (Iannacone et al., 2010).
Measurement of Type I Interferon
Total RNA was extracted from popliteal LNs harvested 8 hr p.i. RNA was
reverse transcribed and real-time quantitative PCR reactions were performed
to detect Ifnb1, Ifna2, Ifna4, and Gapdh message.
In Vivo Depletions and Blockade
LN macrophages were depleted by subcutaneous injections of clodronate
liposomes (CLL), and Thy1+ T cells and NK cells were depleted with an intra-
peritoneal injection of mThy1.2 depleting antibody 4 days prior to and
throughout infection. For lymphotoxing signaling blockade, mice received
weekly intraperitoneal injections of 100 mg of LTbR-mIgG1 for 1, 2, or 3 weeks
prior to infection or tissue harvest.
Statistical Analyses
Results are expressed as mean ± SEM. All statistical analyses were performed
in Prism (GraphPad Software). Means between two groups were compared
with two-tailed t test. Means among three or more groups were compared
with one-way or two-way analysis of variance with Bonferroni’s post-test.
Kaplan-Meier survival curves were compared with the Log-rank (Mantel-
Cox) test.
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